Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis

Fig. 5

Forest plots of AEs rates in studies included. A: Forest plot of thrombocytopenia occurrence rates in MIBG monotherapy. B: Forest plot of thrombocytopenia occurrence rates in studies of 131I-MIBG combined with other therapies. C: Forest plot of neutropenia occurrence rates in MIBG monotherapy. D: Forest plot of neutropenia occurrence rates in studies of 131I-MIBG combined with other therapies

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us